Angela Santoni Selected Research

Histone Deacetylases (Histone Deacetylase)

11/2021	Histone-deacetylase 8 drives the immune response and the growth of glioma.
1/2015	NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angela Santoni Research Topics

Disease

93	Neoplasms (Cancer) 05/2024 - 05/2001
30	Multiple Myeloma 05/2024 - 04/2009
14	Inflammation (Inflammations) 05/2024 - 11/2007
13	Infections 10/2022 - 10/2006
11	Glioma (Gliomas) 11/2021 - 07/2004
8	Virus Diseases (Viral Diseases) 10/2020 - 12/2004
7	Breast Neoplasms (Breast Cancer) 05/2024 - 05/2001
5	Pain (Aches) 04/2022 - 03/2017
5	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2019 - 07/2007
4	Cancer Pain 04/2022 - 07/2002
4	Hyperalgesia 04/2022 - 10/2019
4	Leukemia 01/2022 - 01/2015
4	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 07/2004
4	Carcinoma (Carcinomatosis) 03/2014 - 03/2006
3	Melanoma (Melanoma, Malignant) 01/2019 - 11/2015
3	Urinary Bladder Neoplasms (Bladder Cancer) 04/2015 - 04/2002
2	Neuroinflammatory Diseases 04/2022 - 01/2021
2	COVID-19 01/2022 - 10/2020
2	Hematologic Neoplasms (Hematological Malignancy) 11/2019 - 01/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2019 - 10/2018
2	Rheumatoid Arthritis 01/2019 - 03/2017
2	Lymphopenia (Lymphocytopenia) 10/2017 - 01/2016
2	Osteoarthritis 03/2017 - 01/2017
2	Necrosis 01/2017 - 02/2002
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2015 - 07/2014
2	Lymphoma (Lymphomas) 03/2015 - 01/2003
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2015 - 01/2012
2	Autoimmune Diseases (Autoimmune Disease) 11/2007 - 02/2002
2	Carcinogenesis 03/2007 - 03/2006
1	Bites and Stings (Sting) 05/2024
1	Colitis 10/2023

Drug/Important Bio-Agent (IBA)

43	LigandsIBA 05/2023 - 03/2009
22	CytokinesIBA 01/2023 - 02/2002
15	ChemokinesIBA 01/2021 - 04/2002
14	micaIBA 05/2023 - 07/2007
13	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2003
7	Antiviral Agents (Antivirals)IBA 01/2022 - 08/2006
6	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2005
6	Monoclonal AntibodiesIBA 10/2021 - 05/2001
5	AntigensIBA 10/2022 - 05/2004
5	Opioid Analgesics (Opioids)IBA 04/2022 - 07/2002
5	Interleukin-15 (Interleukin 15)IBA 01/2021 - 05/2012
5	Phosphotransferases (Kinase)IBA 01/2020 - 01/2003
5	AntibodiesIBA 01/2019 - 05/2001
5	Peptides (Polypeptides)IBA 05/2016 - 05/2001
4	Peptide Hydrolases (Proteases)FDA Link 05/2023 - 01/2019
4	Immunomodulating AgentsIBA 01/2021 - 09/2015
4	NF-kappa B (NF-kB)IBA 02/2020 - 01/2005
3	InterleukinsIBA 01/2023 - 10/2006
3	Metalloproteases (Metalloproteinases)IBA 01/2020 - 01/2016
3	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2019 - 01/2003
3	EpitopesIBA 01/2019 - 03/2008
3	UbiquitinIBA 01/2019 - 01/2003
3	Messenger RNA (mRNA)IBA 07/2016 - 07/2010
3	Chemokine ReceptorsIBA 11/2015 - 08/2004
3	Protein Isoforms (Isoforms)IBA 11/2015 - 03/2007
3	Indicators and Reagents (Reagents)IBA 12/2010 - 05/2001
3	Epidermal Growth Factor (EGF)IBA 12/2010 - 03/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2023 - 06/2019
2	MicroRNAs (MicroRNA)IBA 04/2023 - 10/2018
2	Stem Cell FactorIBA 01/2023 - 10/2022
2	TubulinIBA 11/2021 - 08/2015
2	Histone Deacetylases (Histone Deacetylase)IBA 11/2021 - 01/2015
2	Liver X ReceptorsIBA 01/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2016
2	CholesterolIBA 01/2020 - 01/2019
2	RNA (Ribonucleic Acid)IBA 09/2019 - 12/2004
2	Interleukin-12 (IL 12)IBA 09/2019 - 10/2006
2	Small Interfering RNA (siRNA)IBA 06/2019 - 07/2010
2	Immunoglobulin G (IgG)IBA 01/2019 - 05/2004
2	Rituximab (Mabthera)FDA Link 10/2017 - 03/2015
2	Axitinib (AG 013736)IBA 01/2017 - 11/2015
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 11/2015
2	Melphalan (Alkeran)FDA LinkGeneric 01/2017 - 01/2016
2	Docosahexaenoic AcidsIBA 01/2017 - 02/2016
2	CationsIBA 12/2016 - 07/2016
2	Interferon-gamma (Interferon, gamma)IBA 12/2016 - 02/2002
2	Granzymes (Granzyme)IBA 02/2016 - 09/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 01/2015
2	CD226 antigenIBA 01/2015 - 10/2009
2	poliovirus receptorIBA 01/2015 - 06/2013
2	VaccinesIBA 03/2014 - 04/2010
2	Poly I-CIBA 12/2013 - 12/2004
2	ErbB Receptors (EGF Receptor)IBA 12/2010 - 05/2001
2	Chemokine CX3CL1IBA 07/2010 - 04/2010
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2007 - 02/2002
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 05/2024
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 05/2024
1	Interferon Type IIBA 05/2024
1	Adenosine Monophosphate (AMP)IBA 05/2024
1	palbociclibIBA 05/2024
1	pembrolizumabIBA 01/2024
1	enfortumab vedotinIBA 01/2024
1	Dextran SulfateIBA 10/2023
1	Interleukin-13IBA 10/2023

Therapy/Procedure

30	Therapeutics 05/2024 - 04/2002
7	Drug Therapy (Chemotherapy) 01/2020 - 07/2004
7	Immunotherapy 01/2020 - 04/2002
2	Ligation 04/2020 - 01/2018
2	Stem Cell Transplantation 01/2017 - 01/2015